GUGGENHIME ANDREW (CIK 1230724) reported 22 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-09). Recent activity: Sell PCVX (7,155 shares), Sell PCVX (1,273 shares), Sell PCVX (1,432 shares), Buy PCVX (10,000 shares), Sell PCVX (6,956 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 7,155 | $431,876 |
| 2026-09-02 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 1,273 | $77,322 |
| 2026-09-02 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 1,432 | $88,183 |
| 2026-08-05 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Buy | 10,000 | $53,500 |
| 2026-08-05 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 6,956 | $373,962 |
| 2026-08-05 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 3,044 | $164,918 |
| 2026-07-06 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Buy | 10,000 | $53,500 |
| 2026-07-06 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 7,913 | $452,283 |
| 2026-07-06 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 2,087 | $120,553 |
| 2026-06-18 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Buy | 10,000 | $53,500 |
| 2026-06-18 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 10,000 | $530,000 |
| 2026-03-11 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 1,021 | $60,566 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Buy | 44,864 | $0 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 898 | $55,658 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 1,009 | $62,538 |
| 2026-01-16 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 61,850 | $0 |
| 2026-01-16 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Buy | 61,850 | $0 |
| 2025-09-10 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 2,890 | $93,665 |
| 2025-09-04 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 1,270 | $40,081 |
| 2025-09-04 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 2,381 | $75,144 |
| 2025-09-04 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Sell | 1,429 | $45,099 |
| 2025-04-09 | Vaxcyte, Inc. (PCVX) | PRESIDENT AND CFO | Buy | 4,777 | $99,983 |
来源：SEC Form 4 申报文件 · 截至 2026-09-09